Skip to main content

Table 2 Association of baseline variables with stunting, wasting and underweight in 2016

From: Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria

  Stunted Wasted Underweight
  Number (%) Odds ratio P-value Number (%) Odds ratio P-value Number (%) Odds ratio P-value
Gender     < 0.0001    0.11    0.01
 Boy 629 (29.2) 1   488 (22.0) 1   606 (28.1) 1  
 Girl 430 (23.0) 0.71 (0.61–0.83)   381 (19.8) 0.86 (0.70–1.04)   455 (24.3) 0.89 (0.68–0.94)  
Age in months     < 0.0001     < 0.0001     < 0.0001
 3–12 79 (13.5) 1   162 (27.7) 1   132 (22.5) 1  
 13–24 262 (30.4) 3.07 (2.26–4.18)   248 (28.8) 1.04 (0.76–1.42)   272 (31.6) 1.72 (1.29–2.28)  
 25–36 308 (32.2) 3.38 (2.48–4.54)   174 (18.2) 0.48 (0.35–0.67)   277 (28.9) 1.50 (1.13–1.98)  
 37–48 226 (26.9) 2.58 (1.88–3.48)   140 (16.7) 0.41 (0.29–0.58)   195 (23.2) 1.05 (0.79–1.40)  
 48 +  184 (23.6) 2.09 (1.53–2.85)   132 (16.9) 0.44 (0.31–0.63)   185 (23.7) 1.10 (0.82–1.47)  
Country    0.11     < 0.0001     < 0.0001
 Burkina Faso 520 (25.2) 1   552 (26.3) 1   631 (30.5) 1  
 Mali 539 (27.5) 1.13 (0.97–1.32)   317 (15.6) 0.43 (0.35–0.54)   430 (21.9) 0.58 (0.49–0.70)  
Intervention arm    0.25 447 (21.6)   0.28    0.34
 Placebo 547 (27.1) 1   422 (20.4) 1   545 (27.0) 1  
 AZ 512 (25.5) 0.91 (0.79–1.07)    0.89 (0.73–1.10)   516 (25.7) 0.92 (0.78–1.09)  
Distance to health facility    0.004     < 0.0001     < 0.0001
 < 1 km 341 (26.2) 1   194 (14.4) 1   253 (19.5) 1  
 1–4 km 348 (23.5) 0.86 (0.71–1.04)   371 (24.5) 2.24 (1.73–2.90)   426 (28.7) 1.78 (1.44–2.20)  
 5–9 km 220 (29.4) 1.18 (0.95–1.47)   191 (24.8) 2.35 (1.72–3.20)   244 (32.6) 2.22 (1.72–2.86)  
 10 + km 150 (30.4) 1.25 (0.97–1.61)   113 (22.3) 1.86 (1.31–2.64)   138 (27.9) 1.66 (1.25–2.21)  
SP dose (mg/kg)     < 0.0001     < 0.0001    
 < 25 2 (6.9) 0.20 (0.04–0.87)   1 (3.2)753 (18.9) 0.12 (0.01–1.01)   0 (0.0) Not relevanta  
 25–70 986 (25.5) 1   115 (89.8) 1   934 (24.1)   
 > 70 71 (55.9) 4.26 (2.82–6.43)    89.5 (39.7–202)   127 (100.0)   
AQ dose (mg/kg)     < 0.0001     < 0.0001     < 0.0001
 < 10 42 (5.5) 0.15 (0.10–0.21)   33 (4.2) 0.18 (0.12–0.26)   1 (0.1) 0.004 (0.001–003)  
 10–15 605 (25.7) 1   423 (17.4) 1   506 (21.5) 1  
  > 15 412 (45.4) 2.68 (2.20–3.37)   413 (45.3) 5.16 (4.00–6.67)   554 (61.1) 7.05 (5.38–9.25)  
  1. Number and proportion with z < − 2 are shown together with odds ratios and p-values. Likelihood ratio test p-values are presented to indicate a global measure of association
  2. aOR cannot be calculated as prevalence is 0% and 100% in the non-reference groups